Venlafaxine Besylate

苯磺酸文拉法辛

Report date: 2022/07/28 09:58:00

Base Information

Drug NameVenlafaxine Besylate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety Disorders
Global Approved IndicationsDepressive Disorder, MajorAnxiety Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/06/29
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAlmatica Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesAlmatica Pharma LLC
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A